Did you know that women with polycystic ovary syndrome, as well as women in perimenopause or menopause, are at increased risk of MASLD/MASH (formerly known as fatty liver disease)? Find out more here! Learn more: https://drsue.ca/2025/11/what-women-need-to-know-polycystic-ovary-syndrome-perimenopause-and-masld-mash-fatty-liver/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give ...
All content for Dishing The Science with Dr. Sue is the property of Dr. Sue Pedersen and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Did you know that women with polycystic ovary syndrome, as well as women in perimenopause or menopause, are at increased risk of MASLD/MASH (formerly known as fatty liver disease)? Find out more here! Learn more: https://drsue.ca/2025/11/what-women-need-to-know-polycystic-ovary-syndrome-perimenopause-and-masld-mash-fatty-liver/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give ...
How does Mounjaro stack up for cardiovascular protection? The SURPASS CVOT results
Dishing The Science with Dr. Sue
5 minutes
3 months ago
How does Mounjaro stack up for cardiovascular protection? The SURPASS CVOT results
In choosing the best GLP1-based medication for our patients with type 2 diabetes at high risk of cardiovascular disease, guidelines recommend choosing one that has proven reduction in risk of CV events in cardiovascular outcome trials (CVOTs). High level results just released on Mounjaro's SURPASS CVOT study tell us how mounjaro stacks up. Read on to find out! Learn more: https://drsue.ca/2025/08/how-does-mounjaro-stack-up-for-cardiovascular-protection-the-surpass-cvot-results/ Any medical di...
Dishing The Science with Dr. Sue
Did you know that women with polycystic ovary syndrome, as well as women in perimenopause or menopause, are at increased risk of MASLD/MASH (formerly known as fatty liver disease)? Find out more here! Learn more: https://drsue.ca/2025/11/what-women-need-to-know-polycystic-ovary-syndrome-perimenopause-and-masld-mash-fatty-liver/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give ...
